Jörg Paura – Trademark Portfolio
Entity Type: 01
Jörg Paura holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include EPIX, EPITB, EPICOV, EPIPOX, and EPIARBO.
Gudrunstraße 46
22559 Hamburg
Showing of trademarks Trademarks
Trademark Classifications
Jörg Paura's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Jörg Paura have?
Jörg Paura has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Jörg Paura file in?
Jörg Paura files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 16 (Paper Goods), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Jörg Paura's most well-known trademarks?
Jörg Paura's registered trademark portfolio includes well-known marks such as EPIX, EPITB, EPICOV, EPIPOX, and EPIARBO. These are among 5 currently registered trademarks in the portfolio.
What is Jörg Paura's trademark registration success rate?
Jörg Paura has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.